MeBIO is a negative control analogue of BIO, and an aryl hydrocarbon receptor (AhR) agonist. It causes redistribution of AhR to the nucleus. References: Wei F, Diedrich KT, Fullerton HJ, deVeber G, Wintermark M, Hodge J, Kirton A; Vascular Effects of Infection in Pediatric Stroke (VIPS) Investigators. Arterial Tortuosity: An Imaging Biomarker of Childhood Stroke Pathogenesis? Stroke. 2016 May;47(5):1265-70. doi: 10.1161/STROKEAHA.115.011331. Epub 2016 Mar 22. PubMed PMID: 27006453; PubMed Central PMCID: PMC4846544.

纯度：≥98%

CAS：667463-95-8